Treating Common Primary Care Problems Package
Be prepared to treat the most common primary care problems. Fitzgerald’s expert faculty shares their primary care knowledge in this comprehensive program.
Included Courses
Courses included in this package. Click on a course to learn more.
- Allergic Rhinitis: Focus on Assessment and Intervention 1.5 1.5
Learn to differentiate between the common cold, acute bacterial rhinosinusitis (ABRS), and allergic rhinitis (AR).
Dr. Fitzgerald provides evidence-based guidelines for diagnosing and managing AR.
- Case-based Approach to HTN Management: Combination Therapy is Essential 1.25 1.25Discover the critical role of combination therapy in achieving optimal blood pressure control and minimizing the risk of complications in this comprehensive program.
- Clinical Guideline Updates: anxiety, colorectal cancer (CRC), HIV and PrEP, COPD, OSA, and COVID-19 1 1Clinical practice guidelines play a crucial role in optimizing patient care, but keeping pace with their frequent updates can be challenging.
- Common GI Disorders: PUD, gastritis, GERD, ?diarrhea, nausea, vomiting 2 2
A concise and relevant review and update of the assessment and management of peptic ulcer disease, gastritis, gastroesophageal reflux disease, irritable bowel syndrome, and inflammatory bowel disorders.
- Drug-Drug Interactions: Safe Prescribing to Avoid Malpractice 1.5 1.5
The course will focus on:
- Discuss the most common mechanisms for drug-drug interactions
- Discuss techniques to ensure safe prescribing to prevent malpractice
- Review cases involving prescribing errors and medical malpractice cases
- Optimizing Outcomes with Preoperative Assessment 1.5 0Preoperative assessments are commonly conducted in the primary care setting. An NP and CNRA, Monica Tombasco provides the information you need to learn how to perform critical preoperative assessments in your practice.
- Osteoporosis: Primary, Secondary and Tertiary Prevention 2.3 1.2
Run Time: 2
Contact Hours: 2.3
Rx Hours: 1.2Osteoporosis is not inevitable; early diagnosis and treatment can prevent fractures. Learn how to screen, identify who is at risk, and provide evidence-based therapies to treat low bone mass.
- Probiotic and Prebiotic Use in Clinical Practice: What we know, what we are learning 1.5 1.5
Join clinical expert Dr. Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP as she dives into the definitions, types, and forms of probiotics and prebiotics, offering a clear understanding of their role in clinical practice. Explore the potential health benefits of probiotics and prebiotics, supported by the latest emerging scientific research. Participants will gain actionable insights to improve patient care and optimize health outcomes through evidence-based use of probiotics and prebiotics.
- RX Essentials: Diabetes Update: Focus on the latest recommendations 1.5 1.5Effectively managing type 2 diabetes requires keeping pace with evolving evidence and innovative approaches. Join clinical expert Dr. Margaret A. Fitzgerald, DNP, FNP-BC, NP-C, FAANP, CSP, FAAN, DCC, FNAP for an in-depth exploration of the latest recommendations in managing type 2 diabetes.
- Sleep Medications in Primary Care: How to Choose, What to Avoid 1.5 1.5Enhance your knowledge of sleep medications in primary care with this comprehensive program.
- Treatment Guideline Updates: GI, ID, Cardiology, Respiratory, and Dermatology 1.6 1.6
Run Time: 1.4
Contact Hours: 1.6
Rx Hours: 1.6Dr. Fitzgerald reviews the latest clinical practice guideline updates on chronic proton pump inhibitor use, Clostridium difficile infection, acne vulgaris treatment options, COPD, and ADA Standards of Medical Care in Diabetes 2018.
- What's New with AHA/ACC Guidelines for the Management of Lipid Disorders? 1.5 1.5This program presents the most current guideline updates and pharmacologic options for lipid management recommended by the American College of Cardiology/American Heart Association. With a focus on atherosclerotic cardiovascular disease risk reduction, medical history, lipid panel, and CAC scoring are analyzed. Building upon the HMG-CoA reductase inhibitors, additional therapeutic agents for the high-risk patient are considered, with the latest evidence-based analysis of indication, risk, and safety. Cholesterol absorption inhibitors, PCSK9 inhibitors, and ACL inhibitors are all explored as they apply to current guideline-driven management.